Rotterdam, Jil
Thiaucourt, Margot
Weiss, Christel
Schwaab, Juliana
Reiter, Andreas
Kreil, Sebastian
Steiner, Laurenz
Fenchel, Sebastian
Popp, Henning D.
Hofmann, Wolf-Karsten
Bonatz, Karin
Gerhards, Catharina
Neumaier, Michael
Klein, Stefan A.
Rao, Sonika
Jawhar, Mohamad
Saussele, Susanne http://orcid.org/0000-0003-0357-5785
Funding for this research was provided by:
Medizinische Fakultät Heidelberg der Universität Heidelberg
Article History
Received: 31 January 2022
Accepted: 9 May 2022
First Online: 21 May 2022
Declarations
:
: This observational single-center study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.The study was approved by the ethic committee of the University Hospital Mannheim, Heidelberg University, Germany (2021–868-AF 11).
: Dr. Saussele received honoraria by Novartis, Bristol Myer Squibb (BMS), Incyte, Pfizer, and Roche, and research funding by Novartis, BMS, and Incyte. Dr. Reiter received research funding by Blueprint Medicines, Novartis, BMS/Celgene, Incyte, AbbVie, AOP, and GSK, and honoraria by Blueprint Medicines, Novartis, BMS/Celgene, Incyte, AOP, and GSK and has served on advisory boards for Blueprint Medicines, Novartis, BMS/Celgene, Incyte, AbbVie, and AOP. The remaining authors have no competing interests to declare that are relevant to the content of this article.The scientific work on which this publication is based was not financially supported. The abovementioned financial support therefore should not constitute a conflict of interest.